ACS Chemical Biology Archives - Sanford Burnham Prebys
Institute News

Using geometry to design new drugs

Authorsgammon
Date

November 19, 2014

In a new study published in ACS Chemical Biology, Sanford-Burnham’s Stefan Riedl and Elena Pasquale created a molecule with an improved ability to block the activation of a cell receptor called EphA4. When EphA4 is activated, it can hinder the ability of neurons to repair themselves and exacerbates certain degenerative processes, such as amyotrophic lateral sclerosis (ALS)—often referred to as Lou Gehrig’s Disease; Alzheimer’s disease; and stroke. The molecule is a cyclic peptide that represents a promising therapeutic lead for targeting neurodegenerative diseases and some cancers. Continue reading “Using geometry to design new drugs”